[Ip-health] Seminar on Drug Pricing: Dr. Ruth Lopert, TPP and Drug Pricing

Elizabeth Rajasingh elizabeth.rajasingh at keionline.org
Fri Jul 17 13:11:04 PDT 2015


http://keionline.org/node/2285

On Thursday, 23 July 2015, at 11AM Eastern Time (Washington, DC), KEI will
host a seminar on drug pricing featuring Dr. Ruth Lopert, the Deputy
Director of Pharmaceutical Policy and Strategy at the Center for
Pharmaceutical Management, at Management Sciences for Health (MSH).

The seminar will take place at the KEI office in Dupont Circle, and up to
15 persons can be participate remotely, via a video Google Hangout link.
There is also an option to participate via telephone. If there is a
capacity issue for the remote participation by video, we will give priority
to academics, government officials, NGOs working on drug pricing, and third
party payers.

After the seminar, the discussion will be posted online via YouTube and
will be available to the public for research and reference purposes.

Dr. Lopert will begin with a short presentation about the impact of the TPP
on drug prices and also speak more broadly on how governments should set
drug prices, and the types of information needed for this task.
Dr. Lopert was a key negotiator for the U.S.-Australian FTA and can provide
key insights into this process and the potential implications of the TPP.

If you would like to participate, either through GoogleHangouts or in
persion at our DC office, please fill out this Google Poll (
http://goo.gl/forms/E9fXx4kQmH). Please contact Claire Cassedy via
claire.cassedy[at]keionline.org with any additional questions. She will
send out additional information regarding the seminar and instructions
about joining the seminar on the morning of the event.

Ruth Lopert

Dr. Lopert is currently the Deputy Director of Pharmaceutical Policy and
Strategy at the Center for Pharmaceutical Management at MSG. She is also an
adjunct professor in the Department of Health Policy at George Washington
University and a consultant at the World Bank. Previously, Dr. Lopert was
Principal Medical Adviser in Australia’s counterpart FDA agency, the
Therapeutic Goods Administration and in 2006-07 was a Commonwealth Fund
Harkness Fellow in Health Policy. She attended the University of Newcastle
and the Australian National University and is the co-author of several
papers regarding drug pricing.

----
Elizabeth Rajasingh
Perls Research and Policy Fellow, Knowledge Ecology International
1621 Connecticut Ave. NW, Suite 500
Washington, DC 20009
*elizabeth.rajasingh at keionline.org <elizabeth.rajasingh at keionline.org>* |
 1-202-332-2670



More information about the Ip-health mailing list